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Introduction
Acute and chronic musculoskeletal soft-tissue injuries are common 
during participation in physical activity.1 Multiple extrinsic and in-
trinsic risk factors are implicated in the aetiology of these complex 
injuries.2,3 In two specific injuries, anterior cruciate ligament (ACL) 
ruptures and chronic Achilles tendinopathy, genetic components 
have been identified as intrinsic risk factors. Among the genetic risk 
factors identified, the CO5A1 BstUI restriction fragment length poly-
morphism (RFLP) has been associated with both chronic Achilles 
tendinopathy and ACL ruptures.3-5
The CC genotype of the COL5A1 BstUI RFLP was significantly 
over-represented in asymptomatic participants compared with those 
with chronic Achilles tendinopathy – both in South African4 and 
Australian3 populations. A similar finding was reported when female 
participants with ACL ruptures were compared with asymptomatic 
female controls.5 All control groups in these studies were matched 
for physical activity and physiological characteristics. These 
data suggest that individuals with a CC genotype are protected, 
despite the particular load and/or external forces applied to their 
musculoskeletal soft tissues. However, the CC genotype of the 
COL5A1 BstUI RFLP was not over-represented in male subjects with 
ACL ruptures compared with asymptomatic male controls.5 Owing to 
the reported increased risk of ACL ruptures among females, the ACL 
study analysed males and females separately. The previous two 
Achilles tendinopathy studies only analysed males and females as 
one group. 
Interestingly, the CC genotype frequency of the male asymptomatic 
participants of the ACL study was distinctly lower than the CC 
genotype frequencies of the asymptomatic control cohorts in which 
the CC genotype was over-represented.3-5 Furthermore, the male 
asymptomatic participants of the ACL study were approximately 10 
years younger than the asymptomatic control groups in the previous 
two Achilles tendinopathy studies.
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aim. The aim of this study was therefore to determine whether 
the distribution of the COL5A1 BstUI RFLP in the combined 
asymptomatic participants without any known history of tendon 
injuries is age dependent, particularly among males. 
results. When the 265 male asymptomatic participants from all 
studies were pooled and divided into age-group tertiles, there 
was a significant linear increase in the CC genotype frequency 
(p=0.032) among the male age groups, with the youngest group 
having the lowest frequency (CC genotype frequency, 13%) and 
the oldest group having the highest (CC genotype frequency, 
27%) frequency.  There was however a similar CC genotype con-
tent in all three female (N=231) age groups (CC genotype fre-
quency, 24 - 27%; p=0.795). 
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conclusion. The practical implication is that the selection of 
asymptomatic groups is of critical importance when future stud-
ies of this nature are designed. Future research investigating this 
genetic variant as a risk factor for soft-tissue injuries should con-
sider these findings when selecting asymptomatic participants.
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The objective of this study was therefore to further examine the 
age- and sex-related changes in the COL5A1 BstUI RFLP genotype 
frequency among the combined asymptomatic participants. 
More specifically, our primary aim was to determine if the CC 
genotype frequency of the COL5A1 BstUI RFLP among male and 
female subjects without a previous history of tendon injury is age 
dependent. 
Methods 
All 496 asymptomatic participants (265 male and 231 female) with-
out a reported history of tendon injuries that were previously investi-
gated in three separate publications were included in this analysis.3-5 
Because of the design of the previous tendinopathy studies, it was 
not possible to exclude those with a history of ligament injuries. Prior 
to participation in these original studies, all participants gave writ-
ten informed consent and completed a medical history questionnaire 
form. All descriptive data for the subjects with Achilles tendinopa-
thy, as well as the asymptomatic control groups, were  previously 
reported.3-5 All three studies were approved by the Research Eth-
ics Committee of the Faculty of Health Sciences of the University of 
Cape Town and/or the Human Ethics Committee of La Trobe Univer-
sity, Melbourne, Australia.
The participants were combined and divided into three male and 
three female age groups: (i) ≤25 years old; (ii) 26 - 42 years old; and 
(iii) ≥43 years old. A chi-squared (χ2) test, Fisher’s exact test or χ2 
test for linear trends was used to analyse differences in genotype and 
any other categorical data between the groups. Data were analysed 
using STATISTICA Version 8.0 (Statsoft Inc., Tulsa, Oklahoma, USA) 
and Graphpad InStat Version 3 (Graphpad Software, San Diego, 
California, USA) statistical programs. Statistical significance was 
accepted when p<0.05. A one-way analysis of variance (ANOVA) 
was used to determine any significant difference between the 
characteristics of the male and female age groups. Hardy-Weinberg 
equilibrium values were established using the program Genepop 
web version 3.4 (http://genepop.curtin.edu.au/).
results
There was a significant linear trend (p=0.032) for the CC genotype 
frequency among the male age groups (Fig. 1A). The youngest 
group had the lowest CC frequency (13%), and the oldest group the 
highest CC frequency (27%) (Fig. 1A). The CC genotype content in 
all three female age groups (24 - 27%) was similar (p=0.795, Fig. 
1B). The general characteristics of the male and female age group 
tertiles are described in Table I.
Table I.  The general physiological characteristics of the male and female age group tertiles
    ≤25-year group  26 - 42-year group  ≥43-year group  p-value
Males            N=83            N=112          N=70
Age (yrs)       22.3±1.7*†         33.0±5.0*‡      52.6±8.2†‡
           (18 - 25)          (26 - 42)         (43 - 77)  <0.001
Height (cm)          180±6            180±6          178±7
        (168 - 195)        (167 - 201)      (164 - 195)  0.590
Weight (kg)       79.9±11.5         81.4±12.2       81.9±15.0
      (61.7 - 110.0)       (59.7 - 137.0)    (58.0 - 136.0)  0.065
BMI (kg/m2)       24.5±2.8§          25.2±3.4       26.0±4.3§
       (18.5 - 31.7)       (19.9 - 38.4)     (20.2 - 39.3)  0.036
South African born (%)          79.5*†             47.7*          40.5†   <0.001
Australian born (%)         10.3              29.4          36.2
Females            N=63            N=108          N=60
Age (yrs)      22.6±1.7*†        32.4±4.5*‡      52.0±6.7†‡
         (19 - 25)           (26 - 42)       (43 - 72)  <0.001
Height (cm)         166±7           168±7‡        164±8‡
        (152 - 179)         (152 - 187)     (145 - 181)  0.004
Weight (kg)         61.2±6.5          64.4±9.0     81.9±15.0
        (49.0 - 79.2)        (48.0 - 87.0)    (47.0 - 115.0)  0.051
BMI (kg/m2)        22.1±2.1†          22.9±3.0       24.1±4.6†
        (18.1 - 28.1)       (18.1 - 33.2)    (18.6 - 46.7)  0.005
South African born (%)          66.1*†             31.5*          21.7†   <0.001
Australian born (%)          25.4              48.2          56.7
Values are expressed as mean ± standard deviation with the range in parentheses or as a frequency. The number (N) of male and female participants in each age group is also indicated. 
BMI – body mass index. 
Post-hoc analysis: *<0.001; †<0.003; ‡≤0.002; §=0.026.
discussion
The main finding of this study was that there is a significant age-
dependent increase in the distribution of the COL5A1 BstUI RFLP 
CC genotype in the pooled asymptomatic male participants of the 
three studies which investigated this polymorphism as a possible risk 
factor for musculoskeletal soft-tissue injuries. No similar trends were 
observed in the female subjects.
We propose that the reported finding indicates that the youngest 
group of asymptomatic male participants consists of a mixture of 
individuals, similar to the general population, who are at low and high 
risk of musculoskeletal soft-tissue injuries (Fig. 2). However, when 
older subjects (who would have had a greater amount of exposure 
to extrinsic factors) are analysed, individuals who may have been 
previously uninjured, would have developed an injury. Therefore, 
when older asymptomatic participants are analysed, the group will 
contain a highly selected sample of the population at low risk of 
musculoskeletal soft-tissue injuries. This could explain the finding of 
a significant linear trend in the COL5A1 BstUI RFLP CC genotype 
frequency and an increased chronological age in the male subjects 
analysed. This proposed explanation is further supported by a 
departure from Hardy-Weinberg equilibrium as observed in some of 
the groups presented in our previous studies.3 
It remains unknown why a similar trend was not observed in 
females. It does however suggest that the COL5A1 BstUI RFLP, 
as a risk factor for musculoskeletal soft-tissue injuries, is not age 
dependent in females.
A limitation of this study was that it was not possible to analyse 
the South African and Australian data separately owing to small 
sample sizes and uneven genotype distribution. A further limitation 
was that, although all participants were asymptomatic with regard to 
a previous history of tendon injuries,3-5 not all were free of ligament 
injuries (owing to the study designs). 
In conclusion, there was an age-dependent significant increase 
in distribution of the COL5A1 BstUI RFLP CC genotype in the 
pooled asymptomatic male participants of the three studies which 
previously investigated this polymorphism as a possible risk factor 
for soft-tissue injuries. The practical implication of this finding is that 
the selection of control groups is of critical importance when future 
studies of this nature are designed. Future research investigating 
this genetic variant as a risk factor for soft-tissue injuries should 
consider the findings of this study when selecting an asymptomatic 
control group.
perspective
Genetic variants, such as the COL5A1 BstUI RFLP, may have a 
significant impact on the prevention of musculoskeletal soft-tissue 
injures.6 Genetic variants, together with other intrinsic and extrin-
sic risk factors, should eventually be used to identify individuals at 
increased risk of injury. Once individuals are identified as ‘at risk’, 
carefully designed intervention programmes should be prescribed to 
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Fig. 2. Proposed explanation for the significant linear trend in 
CC genotype frequency among the asymptomatic male subjects 
when divided into the three age groups (<25 years, 25 - 41 years, 
and >41 years). It is proposed that asymptomatic subjects in the 
age category <25 years will more than likely consist of individu-
als at high (black shaded) and low (no shade) risk of muscu-
loskeletal soft-tissue injury. Among older asymptomatic groups 
of participants (25 - 41 years, and >41 years) the relative propor-
tion of individuals at high risk of injury will be reduced, as the 
likelihood of high-risk individuals becoming injured over time 
is greater than the likelihood of low-risk individuals becoming 
injured.
Fig. 1. The genotype frequency of the COL5A1 BstUI restric-
tion fragment length polymorphism (RFLP) in all (A) male and 
(B) female asymptomatic participants divided according to age 
into participants (≤25 years old black bars), 26 - 42 years old 
(thatched bars), and  >42 years old (clear bars). A significant 
linear trend (p=0.032) for the CC genotype content among the 
male age groups was found. The number of subjects (n) within 
each category, as well as the Hardy-Weinberg equilibrium (HWE) 
p-values, are shown in parentheses.
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prevent the injury from occurring and to assist the clinical manage-
ment of these individuals. The current study provides further infor-
mation on the COL5A1 BstUI RFLP. The findings may help future 
studies investigating this genetic variant as a risk factor for musculo- 
skeletal soft-tissue injuries and thereby assist future multifactorial 
risk models. 
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